Stocktoria
NOVANTA INC NOVT
NOVANTA INC (NOVT) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $980.6M at a 5.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.26 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-13 | Baird | Outperform (main) |
| 2026-03-30 | Baird | Outperform (up) |
| 2025-08-11 | Baird | Neutral (main) |
| 2025-03-03 | Baird | Neutral (main) |
| 2024-11-06 | Baird | Neutral (main) |
| 2024-08-07 | Baird | Neutral (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.316 |
| Retained earnings / assets | 0.178 |
| EBIT / assets | 0.052 |
| Equity / liabilities | 2.667 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NOVT | NOVANTA INC | 5/9 | 5.8 | 104.2 | +3.3% |
| MVST | Microvast Holdings, Inc. | 5/9 | -3.13 | — | +12.6% |
| CHPT | ChargePoint Holdings, Inc. | 5/9 | -9.79 | — | -1.4% |
| NRGV | Energy Vault Holdings, Inc. | 4/9 | -7.28 | — | +340.9% |
| CBAT | CBAK Energy Technology, Inc. | 3/9 | -2.78 | — | +10.5% |
| ULBI | ULTRALIFE CORP | 5/9 | 2.86 | — | +16.2% |
| BYRN | Byrna Technologies Inc. | 3/9 | 6.43 | 13.4 | +37.7% |
About NOVANTA INC
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
FAQ
Is NOVT financially healthy?
NOVANTA INC's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does NOVT pay a dividend?
No, NOVANTA INC does not currently pay a dividend.
How profitable is NOVT?
In FY2025, NOVANTA INC had a net margin of 5.5% and a return on equity of 4.1%.
Is NOVT overvalued or undervalued?
NOVANTA INC trades at about 113.6× trailing earnings — above its 10-year norm (10-year range 35.5×–99.9×, median 78.9×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for NOVT?
The average Wall-Street price target for NOVANTA INC is $175.00, about 4.8% above the recent price, from 2 analysts (consensus: strong buy).
Is NOVT a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on NOVANTA INC: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 104.2×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.